JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022

Final dividend in bonus shares for the year ended December 31, 2021

Final dividend in bonus shares for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

COMPLETION OF GRANT REGISTRATION UNDER THE 2021 RESTRICTED SHARE INCENTIVE SCHEME

COMPLETION OF GRANT REGISTRATION UNDER THE 2021 RESTRICTED SHARE INCENTIVE SCHEME

Terms of Reference of the Audit Committee of the Board of Directors

Terms of Reference of the Audit Committee of the Board of Directors

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

(1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

Final dividend in bonus shares for the year ended December 31, 2021

Final dividend in bonus shares for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top